- Policy
- Most clinics have 60,000 calling in prescriptions
- by Kim, Jung-Ju Apr 21, 2020 06:27am
- COVID-19 outbreak showed that the government has temporarily allowed some phone consultations and prescriptions, and until recently, Clinics claimed about 60,000 cases, most actively making phone calls. The total amount of medical treatment totaled &8361;1.28 million, of which the total amount of clinics was &8361;736.7 million. The MFD
- Policy
- Futhan, clinical trial of COVID-19 pneumonia treatment
- by Lee, Tak-Sun Apr 21, 2020 06:26am
- Futan (Nafamostat mesylate, SK Chemicals), which is used as an anticoagulant for hemodialysis patients and patients with acute pancreatitis, begins clinical trials in patients with COVID-19 pneumonia. The MFDS approved Sponsor-Investigator Trials on the treatment effect of Futhan's COVID-19 pneumonia patients submitted by Gyeongsang Nation
- Policy
- MOHW to consider HIPDC meeting after stabilizing outbreak
- by Kim, Jung-Ju Apr 21, 2020 06:26am
- The Korean government has announced major vis-à-vis meetings like Health Insurance Policy Deliberation Committee (HIPDC) would be scheduled after the COVID-19 outbreak is better contained. Although international experts view the COVID-19 curve in Korea has been bent, the government has not halted its effort to control the outbreak
- Policy
- Pan-government working group for COVID-19 was established
- by Kim, Jung-Ju Apr 21, 2020 06:26am
- Pan-government working group for the development of treatments and vaccines for COVID-19, a public-private joint government presided over by the President, was established. In the future, the Working Group plans to serve not only for R&D, but also for full-time support such as production, national stockpiling, and the use of a quarantine site
- Policy
- The NHIS agreed the drug price negotiation rate to 95.5%.
- by Lee, Hye-Kyung Apr 20, 2020 06:30am
- The NHIS last year negotiated drug prices on 176 items, including new drugs. Of these, 96.5%, 168 items, completed the drug price negotiations, and 8 items had to be broken. Looking at the current status of the NHIS, which Dailypharm confirmed on the 7th, has negotiated the drug price in the past 6 years, a total of 870 drug price negotiation
- Policy
- Strong sanctions, to expel drugs through re-evaluation
- by Lee, Hye-Kyung Apr 17, 2020 06:22am
- It was suggested that strong sanctions to ban prescriptions as a way to expel drugs that have not been proven safe and effective through re-evaluation of benefits. It is necessary to take effective administrative measures beyond the preparation of a plan for drug withdrawal by the Minister of Health and Welfare, based on the National Health I
- Policy
- Domestic vaccine for COVID-19 developed within 2 years
- by Kim, Jung-Ju Apr 17, 2020 06:21am
- The government will immediately implement measures to support for the development of COVID-19 treatment and vaccines. The goal is to release antibody drugs as early as next year, blood plasma treatment within 2-3 months, and vaccines within 2 years. Tae-ho Yoon, the head of the quarantine, the Central Emergency Government Headquarters o
- Policy
- Exemption of some in vivo tests when developing COVID-19
- by Lee, Tak-Sun Apr 14, 2020 06:12am
- The MFDS decided to exempt in vivo tests on some of the formulations for rapid clinical entry of COVID-19 treatments. In order to enter the clinical trial, in vitro and in vivo studies should be completed and reviewed, but in some formulations, such as antiviral drugs, in vivo studies can be replaced with existing test results. Accordin
- Policy
- Saxenda's upgraded injection (once a week) will be imminent
- by Lee, Tak-Sun Apr 14, 2020 06:11am
- Saxenda's upgraded version of the drug, which is causing a sensation in the domestic obesity treatment market, is predicting clinical trials in Korea, attracting attention. It was Ozempic (Semaglutide), which improved the convenience of administration by injection once a week. The MFDS approved IND for Semaglutide applied by Novonordisk
- Policy
- The government, cuts health insurance premiums by 50%
- by Kim, Jung-Ju Apr 14, 2020 06:11am
- The government has decided to temporarily cut down some health insurance premiums to alleviate the economic damage of low-income and small business owners. The Ministry of Health and Welfare (Minister Park Neung-hoo) announced on the 10th that from March to May, it would reduce (30-50%) the health insurance premiums of the bottom 50% in s
